10th Antibody Industrial Symposium 2022
Join us in Montpellier, France for the 10th AIS, jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign as the ideal conference to exchange expertise about therapeutic antibodies.
- Christelle Dageoneau, Ph.D., SVP Business Development at Just-Evotec Biologics
- Thierry Wurch, Ph.D., SVP, Integrated Biologics Discovery at Evotec
- Nigel Shipston, Senior Director Alliance Management at Just-Evotec Biologics
How AI, ML and intensified continuous manufacturing technologies can support biologics pipeline from lead generation to BLA
During this session, Christelle Dagoneau will present a unique platform concept which integrates the discovery, design, engineering, development, and manufacture of biologics in very flexible and easily deployable production facilities called J.POD. She will also describe how the Just-Evotec Biologics cutting-edge AI/ML protein design technologies combined with industry-leading intensified continuous bioprocess can help de-risk and accelerate biotherapeutics development from lead generation through to BLA while offering reliable and flexible clinical to commercial supply.
Presented by Christelle Dageoneau, Ph.D., SVP Business Development at Just-Evotec Biologics
AI-Derived Antibodies are novel, diverse and pharmacologically active against multiple SARS-CoV-2 strains
Presented by Thierry Wurch, Ph.D., SVP Integrated Biologics Discovery at Evotec
Christelle DagoneauSVP Business Development
Christelle has over 20 years of international business development and marketing experience in the life sciences and biologics CDMO industry. In her current role as SVP Business Development, Christelle leads the global Business Development team, with a focus on shaping innovative business strategies, building a strong industry presence and establishing Just – Evotec Biologics as a global leader in the AI-driven discovery to continuous manufacturing space. Prior to joining Just – Evotec Biologics, Christelle held several senior Business Development roles at Catalent where she supported the growth of the biologics division in Europe and led the European Cell Therapy Business Development team. Christelle also served as Head of Marketing and Sales at PX’Therapeutics, a French biologics CDMO and brings in an expert knowledge of the biotherapeutics and biosimilars markets, a passion for building strategic partnerships as well as strong Business Development culture and best practices.
Christelle received her Ph.D. in Organic Chemistry from the University of Grenoble, France and also holds a master in Technology & Business Management.
Thierry WurchSVP, Integrated Biologics Discovery
Thierry joined Evotec in May 2022 as SVP Integrated Biologics Discovery. He has more than 22 years of expertise in the antibody R&D space primarily in Oncology and immune-oncology. Thierry held positions of growing strategic importance from head of an antibody discovery and engineering department (Pierre Fabre, 2003-2011), head of immunotherapy discovery research activities (Servier, 2011-2017) then moving to BD-oriented activities and heading external innovation for Oncology (Servier, 2017-2020 and Ipsen 2020-2022). Thierry is also Chairman of the antibody sub-committee at NC-IUPHAR, member of the Editorial board of mAbs Journal and Distinguished Advisor of The Antibody Society.